Related Articles for PubMed (Select 18564426)

The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.

Gilleard O, Goodman A, Cooper M, Davies M, Dunn J.

World J Surg Oncol. 2008 Jun 18;6:61.

PMID: 18564426 [PubMed - indexed for MEDLINE]

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID: 17687650 [PubMed - indexed for MEDLINE]

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.

Br J Surg. 2003 Apr;90(4):426-32.

PMID: 12673743 [PubMed - indexed for MEDLINE]

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.

de Mascarel I, Bonichon F, MacGrogan G, de Lara CT, Avril A, Picot V, Durand M, Mauriac L, Trojani M, Coindre JM.

Breast Cancer Res Treat. 2000 May;61(2):151-9.

PMID: 10942101 [PubMed - indexed for MEDLINE]

An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.

MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE.

Cancer. 2007 Dec 15;110(12):2648-53.

PMID: 17960606 [PubMed - indexed for MEDLINE]

A prognostic index for ductal carcinoma in situ of the breast.

Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN.

Cancer. 1996 Jun 1;77(11):2267-74.

PMID: 8635094 [PubMed - indexed for MEDLINE]

The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.

Asjoe FT, Altintas S, Colpaert C, Marck EV, Vermorken JB, Tjalma WA.

Breast J. 2007 Jul-Aug;13(4):359-67.

PMID: 17593040 [PubMed - indexed for MEDLINE]

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.

Silverstein MJ.

Am J Surg. 2003 Oct;186(4):337-43.

PMID: 14553846 [PubMed - indexed for MEDLINE]

Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project.

Dodwell D, Clements K, Lawrence G, Kearins O, Thomson CS, Dewar J, Bishop H; Sloane Project Steering Group.

Br J Cancer. 2007 Sep 17;97(6):725-9.

PMID: 17848911 [PubMed - indexed for MEDLINE]

10:

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8.

PMID: 18199204 [PubMed - indexed for MEDLINE]

11:

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.

Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.

Cancer. 2004 Jun 1;100(11):2317-27.

PMID: 15160334 [PubMed - indexed for MEDLINE]

12:

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID: 12459354 [PubMed - indexed for MEDLINE]

13:

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID: 16005576 [PubMed - indexed for MEDLINE]

14:

[Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature]

Denoux Y, Marnay J, Crouet H, Boute V, Delozier T, Vie B, Chasle J.

Bull Cancer. 2001 Apr;88(4):419-25. Review. French.

PMID: 11371378 [PubMed - indexed for MEDLINE]

15:

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID: 16978943 [PubMed - indexed for MEDLINE]

16:

An argument against routine use of radiotherapy for ductal carcinoma in situ.

Silverstein MJ.

Oncology (Williston Park). 2003 Nov;17(11):1511-33; discussion 1533-4, 1539, 1542 passim. Review.

PMID: 14682107 [PubMed - indexed for MEDLINE]

17:

Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.

Ringberg A, Idvall I, Fernö M, Anderson H, Anagnostaki L, Boiesen P, Bondesson L, Holm E, Johansson S, Lindholm K, Ljungberg O, Ostberg G.

Eur J Surg Oncol. 2000 Aug;26(5):444-51.

PMID: 11016463 [PubMed - indexed for MEDLINE]

18:

Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision.

Vapiwala N, Harris E, Hwang WT, Solin LJ.

Cancer J. 2006 Jan-Feb;12(1):25-32.

PMID: 16613659 [PubMed - indexed for MEDLINE]

19:

Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.

Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, Duda RB, Guidi AJ, Kaelin CM, Silver EB, Harris JR.

Cancer J Sci Am. 1995 May-Jun;1(1):55-61.

PMID: 9166455 [PubMed - indexed for MEDLINE]

20:

Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?

Yerushalmi R, Sulkes A, Mishaeli M, Neumann A, Dinerman M, Sulkes J, Rizel S, Yarom N, Gutman H, Fenig E.

Neoplasma. 2006;53(6):507-10.

PMID: 17167720 [PubMed - indexed for MEDLINE]

Recent Activity